Atara Biotherapeutics (ATRA) Q4 2024 Earnings Report
CH:ATRA Q4 2024 EPS Results
- Actual EPS
- -CHF 0.98
- Consensus EPS
- -CHF 2.36
- Beat/Miss
- Beat by +CHF 1.38
- One Year Ago EPS
- -CHF 11.55
CH:ATRA Q4 2024 Revenue Results
- Actual Revenue
- CHF 27.01M
- Expected Revenue
- CHF 16.98M
- Beat/Miss
- Beat by +CHF 10.04M
- YoY Revenue Growth
- +670.30%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 03/07/2025
- Time
- After Close
- Conference Call
- Friday, March 7, 2025
CH:ATRA Upcoming Earnings
Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ATRA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | ―- | -0.21 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.11- | -0.26 | ― | |
| Aug 12, 2026 | 2026 (Q2) | -0.26-0.26 | 0.16 | -268.42% (-0.42) | |
| May 12, 2026 | 2026 (Q1) | -0.27-0.24 | 2.89 | -108.29% (-3.13) | |
| Mar 16, 2026 | 2025 (Q4) | -0.15-0.21 | -0.98 | 78.99% (+0.78) | |
| Nov 29, 2025 | 2025 (Q3) | -0.55-0.26 | -2.42 | 89.08% (+2.15) | |
| Aug 11, 2025 | 2025 (Q2) | -0.050.16 | -2.56 | 106.13% (+2.71) | |
| May 15, 2025 | 2025 (Q1) | -1.632.89 | -4.74 | 160.87% (+7.63) | |
| Mar 07, 2025 | 2024 (Q4) | -2.36-0.98 | -11.55 | 91.50% (+10.57) | |
| Nov 12, 2024 | 2024 (Q3) | -1.56-2.42 | -13.61 | 82.24% (+11.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed